KraneShares Emerging Markets Healthcare Index ETF
KMED
KMED was delisted on the 18th of October, 2023.
4 hedge funds and large institutions have $1.68M invested in KraneShares Emerging Markets Healthcare Index ETF in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more capital invested
Capital invested by funds: $1.68M → $1.68M (+$3K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$76K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$51.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.93K |
KMED Hedge Fund Activity: Q1 2021 in Review
4 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q1 2021, worth a combined $1.68M — up 0.18% from $1.68M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new KMED positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $76K. The largest seller was Osaic Holdings, cutting an estimated $1.93K.
- 4 institutional investors held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q1 2021, up from 3 in Q4 2020.
- Funds reported $1.68M of KraneShares Emerging Markets Healthcare Index ETF stock for Q1 2021, up 0.18% quarter-over-quarter.
- 1 fund opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q1 2021 and 0 closed out, a net change of +1 holder.
- The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q1 2021 was Jane Street, an estimated $76K added.
- The largest KraneShares Emerging Markets Healthcare Index ETF seller in Q1 2021 was Osaic Holdings, an estimated $1.93K sold.
Based on aggregated 13F filings for Q1 2021.